Browse by Aston Author

2006

Rathbone, Daniel L.; Parker, Katy J.; Coleman, Michael D.; Lambert, Peter A. and Billington, David C. (2006). Discovery of a potent phenolic N1-benzylidene- pyridinecarboxamidrazone selective against Gram-positive bacteria. Bioorganic and Medicinal Chemistry Letters, 16 (4), pp. 879-883.

2005

Rathbone, Daniel L.; Ali, Aisha; Antonaki, Polyxeni and Cheek, Sarah (2005). Towards a polymeric binding mimic for cytochrome CYP2D6. Biosensors and Bioelectronics, 20 (11), pp. 2353-2363.

Rathbone, Daniel L. and Bains, Ajeet (2005). Tools for fluorescent molecularly imprinted polymers. Biosensors and Bioelectronics, 20 (7), pp. 1438-1442.

2004

Coleman, Michael D.; Khan, Nazish; Welton, Graham; Lambert, Peter A.; Tims, Katy J. and Rathbone, Daniel L. (2004). Effects of glutathione, N-acetyl-cysteine, α-lipoic acid and dihydrolipoic acid on the cytotoxicity of a 2-pyridylcarboxamidrazone antimycobacterial agent in human mononuclear leucocytes in vitro. Environmental Toxicology and Pharmacology, 17 (3), pp. 143-148.

2003

Simpson, Julie; Forrester, Rebecca; Tisdale, Michael J.; Billington, David C. and Rathbone, Daniel L. (2003). Effect of catechol derivatives on cell growth and lipoxygenase activity. Bioorganic and Medicinal Chemistry Letters, 13 (15), pp. 2435-2439.

Coleman, MD; Tims, Katy J. and Rathbone, Daniel L. (2003). The use of computational QSAR analysis in the toxicological evaluation of a series of 2-pyridylcarboxamidrazone candidate anti-tuberculosis compounds. Environmental Toxicology and Pharmacology, 14 (1-2), pp. 33-42.

2002

Thanh, Nguyen Thi Kim; Rathbone, Daniel L.; Billington, David C. and Hartell, Nicholas A. (2002). Selective recognition of cyclic GMP using a fluorescence-based molecularly imprinted polymer. Analytical letters, 35 (15), pp. 2499-2509.

2001

Rathbone, Daniel L. and Ge, Ye (2001). Selectivity of response in fluorescent polymers imprinted with N1-benzylidene pyridine-2-carboxamidrazones. Analytica Chimica Acta, 435 (1), pp. 129-136.

Coleman, Michael D.; Rathbone, Daniel L.; Chima, Rajinda; Lambert, Peter A. and Billington, David C. (2001). Preliminary in vitro toxicological evaluation of a series of 2-pyridylcarboxamidrazone candidate anti-tuberculosis compounds III. Environmental Toxicology and Pharmacology, 9 (3), pp. 99-102.

2000

Schwalbe, Carl H.; Rathbone, Daniel L.; Tims, Katy J.; Billington, David C.; Sandbhor, Uday and Padhye, Subhash (2000). Effects of functional group deletion on structural features and antimycobacterial activity in pyridylcarboxamidrazones. Journal of Pharmacy and Pharmacology, 52 (9 SUPP), p. 105.

Tims, Katy J.; Rathbone, Daniel L.; Lambert, Peter A.; Attkins, Neil; Cann, Stuart W. and Billington, David C. (2000). Mycobacterium fortuitum as a screening model for Mycobacterium tuberculosis. Journal of Pharmacy and Pharmacology, 52 (9 SUPP), p. 135.

Coleman, Michael D.; Rathbone, Daniel L.; Tims, Katie J.; Chima, Rajinda; Hovey, Melanie C.; Endersby, Catrina; Lee, Abberley and Billington, David C. (2000). Predictive toxicity studies on a set of antimycobacterial N′-benzylidene-heteroarylcarboxamidrazones. Journal of Pharmacy and Pharmacology, 52 (9 SUPP), p. 292.

Rathbone, Daniel L.; Tims, Katie J.; Attkins, Neil; Cann, Stuart W. and Billington, David C. (2000). QSAR studies on a large set of antimycobacterial N′-benzylidene-heteroarylcarboxamidrazones. Journal of Pharmacy and Pharmacology, 52 (9 SUPP), p. 97.

Thanh, Nguyen Thi Kim; Rathbone, Daniel L.; Billington, David C. and Iiartell, Nicholas A. (2000). Selective recognition of cGMP using a polymer-based fluorescent chemosensor. Journal of Pharmacy and Pharmacology, 52 (9 SUPP), p. 77.